193 related articles for article (PubMed ID: 32132019)
1. Recurrent Uterine Smooth-Muscle Tumors of Uncertain Malignant Potential (STUMP): State of The Art.
Rizzo A; Ricci AD; Saponara M; DE Leo A; Perrone AM; DE Iaco P; Pantaleo MA; Nannini M
Anticancer Res; 2020 Mar; 40(3):1229-1238. PubMed ID: 32132019
[TBL] [Abstract][Full Text] [Related]
2. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence.
Dall'Asta A; Gizzo S; Musarò A; Quaranta M; Noventa M; Migliavacca C; Sozzi G; Monica M; Mautone D; Berretta R
Int J Clin Exp Pathol; 2014; 7(11):8136-42. PubMed ID: 25550862
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
4. Uterine smooth-muscle tumors of uncertain malignant potential.
Peters WA; Howard DR; Andersen WA; Figge DC
Obstet Gynecol; 1994 Jun; 83(6):1015-20. PubMed ID: 8190416
[TBL] [Abstract][Full Text] [Related]
5. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
Ip PP; Tse KY; Tam KF
Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
[TBL] [Abstract][Full Text] [Related]
7. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
Ip PP; Cheung AN; Clement PB
Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
[TBL] [Abstract][Full Text] [Related]
8. Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.
Croce S; Ribeiro A; Brulard C; Noel JC; Amant F; Stoeckle E; Devouassoux-Shisheborah M; Floquet A; Arnould L; Guyon F; Mishellany F; Garbay D; Cuppens T; Zikan M; Leroux A; Frouin E; Duvillard P; Terrier P; Farre I; Valo I; MacGrogan GM; Chibon F
Mod Pathol; 2015 Jul; 28(7):1001-10. PubMed ID: 25932961
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 Expression and Tumor-infiltrating Lymphocytes in Uterine Smooth Muscle Tumors: Implications for Immunotherapy.
Shanes ED; Friedman LA; Mills AM
Am J Surg Pathol; 2019 Jun; 43(6):792-801. PubMed ID: 31009388
[TBL] [Abstract][Full Text] [Related]
10. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.
Croce S; Ducoulombier A; Ribeiro A; Lesluyes T; Noel JC; Amant F; Guillou L; Stoeckle E; Devouassoux-Shisheboran M; Penel N; Floquet A; Arnould L; Guyon F; Mishellany F; Chakiba C; Cuppens T; Zikan M; Leroux A; Frouin E; Farre I; Genestie C; Valo I; MacGrogan G; Chibon F
Mod Pathol; 2018 May; 31(5):816-828. PubMed ID: 29327710
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic evaluation of uterine smooth muscle tumors of uncertain malignant potential (STUMP): A single center experience.
Karataşlı V; Çakır İ; Ayaz D; Budak A; Sancı M
J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):637-642. PubMed ID: 30898630
[TBL] [Abstract][Full Text] [Related]
12. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
13. The Clinicopathological Study of 21 Cases With Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Centralized Review Can Purify the Diagnosis.
Basaran D; Usubutun A; Salman MC; Narin MA; Boyraz G; Turkmen O; Comert Kimyon G; Karalok A; Bulbul D; Turan T; Ozgul N; Yuce K
Int J Gynecol Cancer; 2018 Feb; 28(2):233-240. PubMed ID: 29303932
[TBL] [Abstract][Full Text] [Related]
14. Uterine smooth muscle tumors of uncertain malignant potential: analysis of diagnoses and therapies illustrated by two case reports.
Peeters N; Hulsbosch S; Ballaux F; Baekelandt J
Eur J Gynaecol Oncol; 2016; 37(3):367-73. PubMed ID: 27352566
[TBL] [Abstract][Full Text] [Related]
15. Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes.
Şahin H; Karatas F; Coban G; Özen Ö; Erdem Ö; Onan MA; Ayhan A
J Gynecol Oncol; 2019 Jul; 30(4):e54. PubMed ID: 31074239
[TBL] [Abstract][Full Text] [Related]
16. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
Mowers EL; Skinner B; McLean K; Reynolds RK
J Minim Invasive Gynecol; 2015; 22(4):601-6. PubMed ID: 25596464
[TBL] [Abstract][Full Text] [Related]
17. Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential.
Conconi D; Chiappa V; Perego P; Redaelli S; Bovo G; Lavitrano M; Milani R; Dalprà L; Lissoni AA
Oncol Rep; 2017 Jan; 37(1):41-47. PubMed ID: 28004108
[TBL] [Abstract][Full Text] [Related]
18. [Smooth muscle tumor of uncertain malignant potential (STUMP)--clinico-pathomorphological analysis of the cases and literature review].
Dańska-Bidzińska A; Bakuła-Zalewska E; Nasierowska-Guttmejer A; Kowalewska M; Barnaś E; Sobiczewski P; Bidziński M
Ginekol Pol; 2012 Jun; 83(6):412-6. PubMed ID: 22880459
[TBL] [Abstract][Full Text] [Related]
19. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
Mittal K; Demopoulos RI
Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience of uterine smooth muscle tumor of uncertain malignant potential in two gynecological centers: Oncological and obstetrical aspects.
Shim JI; Han AKW; Jeon HJ; Kim ML; Jung YW; Yun BS; Seong SJ; Shin E; Cho YJ; Rha SH
Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():7-13. PubMed ID: 31927240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]